Searchable abstracts of presentations at key conferences in endocrinology

ea0035p499 | Diabetes therapy | ECE2014

Differential effects of native Peptide YY and its long acting analogue (Y-59) on innate lymphocyte function and anti-tumour activity

Hogan Andrew , Tobin Laura , Corrigan Michelle , Gilshinan Colm , Ghatei Mohammad , Bloom Stephen , O'Shea Donal

Background: Peptide-YY is synthesised and secreted by specialised cells in the ileum and colon. Levels increase following food intake, having a satiety effect. Baseline and postprandial levels of PYY were found to be lower in obese subjects compared to lean, negatively correlating with the subjects BMI, however obese subjects were sensitive to the anorectic effects of PYY when given exogenous PYY.Hypothesis: We have recently demonstrated that another pra...

ea0035p791 | Obesity | ECE2014

Childhood obesity alters innate T cell frequency and function resulting in loss of regulation and increased inflammation

Hogan Andrew , Carolan Eirin , Mangan Bozgana , Corrigan Michelle , Doherty Derek , Cody Declan , O'Shea Donal

Background: Childhood obesity now represents a major public health concern. Being obese in childhood appears to increase the risk of severe obesity in adulthood. Obesity is associated with co-morbid conditions such as type 2 diabetes and cardiovascular disease. Underpinning obesity is a state of chronic sterile inflammation. Recently the invariant natural killer T (iNKT) cell, an innate T cell was shown to act as a metabolic regulator and altered by obesity both in adults and ...

ea0033oc3.5 | Oral Communications 3 | BSPED2013

Loss of the tumour suppressor micro-RNA 34a, and anti tumour cellular immunity in paediatric obesity – is obesity increasing the future risk of cancer in children?

Carolan Eirin , Hogan Andrew , Corrigan Michelle , O'Connell Jean , Foley Niamh , O'Neill Luke , Cody Declan , O'Shea Donal

There is strong epidemiological data linking obesity to an increased risk of various cancers. It is associated with immune dysregulation and chronic low grade inflammation, however little is known about its impact on anti-tumour immunity. Whether childhood obesity is an independent risk factor for future malignancy is not fully established. We hypothesized that alterations in key immune anti-tumour mechanisms begin prior to adulthood in paediatric obesity.<p class="abstext...

ea0033p64 | (1) | BSPED2013

Immune cell dysregulation – contributing to the risk of development of metabolic disease in childhood obesity

Carolan Eirin , Hogan Andrew , Corrigan Michelle , O'Connell Jean , Foley Niamh , O'Neill Luke , Cody Declan , O'Shea Donal

Background: Although the association between obesity, chronic low-grade inflammation and immune dysregulation is well described in adults, there is a paucity of literature regarding this in children. We hypothesized that childhood obesity is associated with significant immune dysregulation.Methods: Expression of cytokines and microRNAs (miR) involved in the pathogenesis of metabolic disease were assessed in 49 participants aged 6–18 years. Invariant...

ea0031p220 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2013

Hepatic 11β-hydroxysteroid dehydrogenase type 1 is elevated following weight loss secondary to bariatric surgery

Woods Conor , Taylor Angela , Hughes Beverly , Corrigan Michelle , Stewart Paul , Tomlinson Jeremy , Shea Donal O , Sherlock Mark

In the pathogenesis of obesity, dysregulated tissue cortisol metabolism (controlled by 11β-HSD1), is postulated to be involved. Fifteen patients (seven mens, mean BMI 50.8±7 kg/m2) awaiting Roux En Y gastric Bypass (RYGB) surgery underwent assessment of 11β-HSD1 activity using cortisol generation profile. Corticosteroids in serum and subcutaneous adipose tissue microdialysis fluid and urinary corticosteroid metabolites were analysed by liquid and gas ...